Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

BACKGROUND In animal models of heterotopic transplantation, mechanical unloading of the normal, nonhypertrophic heart results in atrophy. Primarily on the basis of these animal data, the notion that chronic left ventricular assist device (LVAD)-induced unloading will result in atrophy has dominated the clinical heart failure field, and anti-atrophic drugs have been used to enhance the cardiac recovery potential observed in some LVAD patients. However, whether unloading-induced atrophy in experimental normal heart models applies to failing and hypertrophic myocardium in heart failure patients unloaded by continuous-flow LVADs has not been studied. OBJECTIVES The study examined whether mechanical unloading by continuous-flow LVAD leads to myocardial atrophy. METHODS We prospectively examined myocardial tissue and hemodynamic and echocardiographic data from 44 LVAD patients and 18 untransplanted normal donors. RESULTS Cardiomyocyte size (cross-sectional area) decreased after LVAD unloading from 1,238 ± 81 μm(2) to 1,011 ± 68 μm(2) (p = 0.001), but not beyond that of normal donor hearts (682 ± 56 μm(2)). Electron microscopy ultrastructural evaluation, cardiomyocyte glycogen content, and echocardiographic assessment of myocardial mass and left ventricular function also did not suggest myocardial atrophy. Consistent with these findings, t-tubule morphology, cytoplasmic penetration, and distance from the ryanodine receptor were not indicative of ongoing atrophic remodeling during LVAD unloading. Molecular analysis revealed no up-regulation of proatrophic genes and proteins of the ubiquitin proteasome system. CONCLUSIONS Structural, ultrastructural, microstructural, metabolic, molecular, and clinical functional data indicated that prolonged continuous-flow LVAD unloading does not induce hypertrophy regression to the point of atrophy and degeneration. These findings may be useful in designing future investigations that combine LVAD unloading and pharmaceutical therapies as a bridge to recovery of the failing heart.

[1]  M. Slaughter,et al.  Clinical, molecular, and genomic changes in response to a left ventricular assist device. , 2011, Journal of the American College of Cardiology.

[2]  G. Cooper,et al.  Atrophy Reversal and Cardiocyte Redifferentiation in Reloaded Cat Myocardium , 1984, Circulation research.

[3]  Dean Y. Li,et al.  Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. , 2010, Journal of the American College of Cardiology.

[4]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[5]  Gregory J. Stoddard,et al.  Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II , 2013, Circulation. Heart failure.

[6]  W. Frishman,et al.  Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure , 2007 .

[7]  K Rakusan,et al.  Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. , 1997, Journal of molecular and cellular cardiology.

[8]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[9]  M. Komeda,et al.  Heterotopic Transplantation of the Failing Rat Heart as a Model of Left Ventricular Mechanical Unloading Toward Recovery , 2005, ASAIO journal.

[10]  S. Pham,et al.  Effects of ventricular unloading on apoptosis and atrophy of cardiac myocytes. , 2004, Journal of Surgical Research.

[11]  D. Kass,et al.  Subcellular Structures and Function of Myocytes Impaired During Heart Failure Are Restored by Cardiac Resynchronization Therapy , 2012, Circulation research.

[12]  Dean Y. Li,et al.  Bridge to Recovery: Understanding the Disconnect Between Clinical and Biological Outcomes , 2012, Circulation.

[13]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[14]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[15]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[16]  J. Passonneau,et al.  A comparison of three methods of glycogen measurement in tissues. , 1974, Analytical biochemistry.

[17]  M. Yacoub,et al.  Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca2+-induced Ca2+release in a rodent model of heart failure , 2012, European journal of heart failure.

[18]  M. Yacoub,et al.  Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure , 2008, Cardiovascular research.

[19]  Frank B. Sachse,et al.  Towards Computational Modeling of Excitation-Contraction Coupling in Cardiac Myocytes: Reconstruction of Structures and Proteins from Confocal Imaging , 2008, Pacific Symposium on Biocomputing.

[20]  P. McNulty,et al.  Effect of nonworking heterotopic transplantation on rat heart glycogen metabolism. , 1995, The American journal of physiology.

[21]  J. Schulz-Menger,et al.  Letter regarding article by Sharkey et al, "Acute and reversible cardiomyopathy provoked by stress in women from the United States". , 2005, Circulation.

[22]  Y. Taenaka,et al.  Influence of prolonged ventricular assistance on myocardial histopathology in intact heart. , 1996, The Annals of thoracic surgery.

[23]  Dean Y. Li,et al.  Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. , 2013, Journal of the American College of Cardiology.

[24]  K. Margulies,et al.  Mixed Messages: Transcription Patterns in Failing and Recovering Human Myocardium , 2005, Circulation research.

[25]  P. Charles,et al.  Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. , 2009, The Journal of thoracic and cardiovascular surgery.

[26]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  K. Margulies,et al.  Unloading-induced remodeling in the normal and hypertrophic left ventricle. , 2003, American journal of physiology. Heart and circulatory physiology.

[28]  Yi-Ping Li,et al.  Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation , 2003, Circulation.

[29]  D. Mancini,et al.  Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling , 2011, Circulation. Heart failure.

[30]  J. Cleveland,et al.  Longitudinal left ventricular structural and functional imaging during full support with continuous-flow ventricular assist devices: a retrospective, preliminary analysis. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  Xinqiang Han,et al.  Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. , 2004, Physiological genomics.

[32]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[33]  P. Razeghi,et al.  Hypertrophy and Atrophy of the Heart , 2006, Annals of the New York Academy of Sciences.

[34]  M. Yacoub,et al.  3 Combination Therapy with Pulsatile Left Ventricular Assist Device, Heart Failure Medication and Clenbuterol in Chronic Heart Failure: Results from HARPS , 2011 .

[35]  Allison R. Schulman,et al.  Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  C. Soeller,et al.  Changes in the Organization of Excitation-Contraction Coupling Structures in Failing Human Heart , 2011, PloS one.

[37]  P. Razeghi,et al.  Atrophic Remodeling of the Transplanted Rat Heart , 2006, Cardiology.

[38]  S. Matsuoka,et al.  Does the β2-Agonist Clenbuterol Help to Maintain Myocardial Potential to Recover During Mechanical Unloading? , 2005, Circulation.

[39]  Francis D. Pagani,et al.  The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported Patients , 2010, Circulation. Heart failure.

[40]  R. Weisel,et al.  Reloading the heart : A new animal model of left ventricular assist device removal , 2005 .

[41]  W. Koch,et al.  Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts. , 2002, The Journal of thoracic and cardiovascular surgery.

[42]  E. Olson,et al.  Cardiac plasticity. , 2008, The New England journal of medicine.

[43]  P. Razeghi,et al.  Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. , 2006, Biochemical and biophysical research communications.

[44]  M. Yacoub,et al.  Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.